| Rosemary G Etheart, CNP | |
|
28105 Clemens Rd, Bldg 3, Westlake, OH 44145-1100 | |
| (440) 788-4500 | |
| (440) 835-4376 |
| Full Name | Rosemary G Etheart |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 33 Years |
| Location | 28105 Clemens Rd, Westlake, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417941428 | NPI | - | NPPES |
| 2577966 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | RN167684 (Ohio) | Secondary |
| 363L00000X | Nurse Practitioner | COA.03116-NP (Ohio) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Primary Care Practices Inc | 3072417534 | 940 |
News Archive
A patient who met many of the published safety guidelines for chloroquine therapy against COVID-19 was observed to have a very abnormal ECG pattern after treatment began, leading to multiple episodes of torsade de pointes (TdP), a life-threatening arrhythmia in which the lower chambers of the heart beat out of sync with the upper chambers.
Schizophrenia affects millions of people worldwide but the cause of its wide-ranging symptoms remains largely unknown.
Sanofi-aventis announced today results from a Phase 3 trial which demonstrated cabazitaxel, an investigational compound, plus prednisone/prednisolone significantly improved overall survival and progression-free survival in patients with metastatic (advanced) hormone-refractory prostate cancer whose disease progressed following treatment with docetaxel-based chemotherapy.
Seeing someone do something good for someone else motivates witnesses to perform their own helpful acts, an insight that could help drive cooperative behavior in communities navigating through the health crisis.
› Verified 5 days ago
| Entity Name | University Primary Care Practices Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003935339 PECOS PAC ID: 3072417534 Enrollment ID: O20031125000767 |
News Archive
A patient who met many of the published safety guidelines for chloroquine therapy against COVID-19 was observed to have a very abnormal ECG pattern after treatment began, leading to multiple episodes of torsade de pointes (TdP), a life-threatening arrhythmia in which the lower chambers of the heart beat out of sync with the upper chambers.
Schizophrenia affects millions of people worldwide but the cause of its wide-ranging symptoms remains largely unknown.
Sanofi-aventis announced today results from a Phase 3 trial which demonstrated cabazitaxel, an investigational compound, plus prednisone/prednisolone significantly improved overall survival and progression-free survival in patients with metastatic (advanced) hormone-refractory prostate cancer whose disease progressed following treatment with docetaxel-based chemotherapy.
Seeing someone do something good for someone else motivates witnesses to perform their own helpful acts, an insight that could help drive cooperative behavior in communities navigating through the health crisis.
› Verified 5 days ago
| Entity Name | Drynachan Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891044657 PECOS PAC ID: 2264718824 Enrollment ID: O20170717003557 |
News Archive
A patient who met many of the published safety guidelines for chloroquine therapy against COVID-19 was observed to have a very abnormal ECG pattern after treatment began, leading to multiple episodes of torsade de pointes (TdP), a life-threatening arrhythmia in which the lower chambers of the heart beat out of sync with the upper chambers.
Schizophrenia affects millions of people worldwide but the cause of its wide-ranging symptoms remains largely unknown.
Sanofi-aventis announced today results from a Phase 3 trial which demonstrated cabazitaxel, an investigational compound, plus prednisone/prednisolone significantly improved overall survival and progression-free survival in patients with metastatic (advanced) hormone-refractory prostate cancer whose disease progressed following treatment with docetaxel-based chemotherapy.
Seeing someone do something good for someone else motivates witnesses to perform their own helpful acts, an insight that could help drive cooperative behavior in communities navigating through the health crisis.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rosemary G Etheart, CNP 26908 Detroit Rd, Suite 301, Westlake, OH 44145-2398 Ph: (440) 617-1823 | Rosemary G Etheart, CNP 28105 Clemens Rd, Bldg 3, Westlake, OH 44145-1100 Ph: (440) 788-4500 |
News Archive
A patient who met many of the published safety guidelines for chloroquine therapy against COVID-19 was observed to have a very abnormal ECG pattern after treatment began, leading to multiple episodes of torsade de pointes (TdP), a life-threatening arrhythmia in which the lower chambers of the heart beat out of sync with the upper chambers.
Schizophrenia affects millions of people worldwide but the cause of its wide-ranging symptoms remains largely unknown.
Sanofi-aventis announced today results from a Phase 3 trial which demonstrated cabazitaxel, an investigational compound, plus prednisone/prednisolone significantly improved overall survival and progression-free survival in patients with metastatic (advanced) hormone-refractory prostate cancer whose disease progressed following treatment with docetaxel-based chemotherapy.
Seeing someone do something good for someone else motivates witnesses to perform their own helpful acts, an insight that could help drive cooperative behavior in communities navigating through the health crisis.
› Verified 5 days ago
Diane M Herron, BS MS BSN MSN CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 25200 Center Ridge Road, Suite 1100, Westlake, OH 44145 Phone: 440-333-3332 Fax: 440-331-3894 | |
Sarah Timko, APRN.CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 27596 Remington Cir, Westlake, OH 44145 Phone: 216-630-2999 | |
Brian G Dyko, CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 29101 Health Campus Dr Bldg 2, Westlake, OH 44145 Phone: 440-250-0325 Fax: 440-250-0467 | |
Jessica N Angell, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 850 Columbia Rd Ste 200, Westlake, OH 44145 Phone: 440-808-1212 Fax: 440-808-2060 | |
Sherry L Armitage, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 25651 Detroit Rd, Suite 304, Westlake, OH 44145 Phone: 440-808-8620 | |
Geralyn R Costello, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 29000 Center Ridge Rd, Westlake, OH 44145 Phone: 440-835-8000 | |
Chelsea Marie Maiberger, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 27442 Dunford Rd, Westlake, OH 44145 Phone: 260-413-8737 |